Thoma Bravo buys Greenphire from Riverside

Jim Murphy, CEO of Greenphire, will continue to lead the clinical trial payments company along with the existing management team.

26 May 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles